Variant report

Variant	esv2455446
Chromosome Location	chr4:130280075-130283664
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:130283641..130284584-chr4:130562058..130562984,3	MCF-7	breast:

Extended variants
information (count: 112 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:112 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540414774	chr4:130280086-130280087	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs558806040	chr4:130280122-130280123	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs577185026	chr4:130280176-130280177	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs367609357	chr4:130280179-130280180	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs75084268	chr4:130280185-130280186	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs562302109	chr4:130280206-130280207	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs529681936	chr4:130280217-130280218	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs563635260	chr4:130280222-130280223	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs112842037	chr4:130280224-130280225	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs565361199	chr4:130280404-130280405	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs191796013	chr4:130280475-130280476	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs183881513	chr4:130280511-130280512	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs117499261	chr4:130280549-130280550	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs568696126	chr4:130280592-130280593	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs187433702	chr4:130280664-130280665	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs374393449	chr4:130280716-130280717	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs191924606	chr4:130280720-130280721	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs138471944	chr4:130280725-130280726	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs141737490	chr4:130280743-130280744	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs528822364	chr4:130280796-130280797	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs537347483	chr4:130280831-130280832	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs547307264	chr4:130280842-130280843	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs548330428	chr4:130280893-130280894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs557103435	chr4:130280925-130280926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs185572188	chr4:130280929-130280930	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs534312849	chr4:130280965-130280966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs372442032	chr4:130280966-130280967	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs117775299	chr4:130281083-130281084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs72927081	chr4:130281084-130281085	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs146257451	chr4:130281085-130281086	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs556417379	chr4:130281086-130281087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs72927083	chr4:130281110-130281111	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs190832092	chr4:130281132-130281133	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs142695637	chr4:130281166-130281167	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs78695647	chr4:130281200-130281201	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs144156478	chr4:130281207-130281208	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs182071066	chr4:130281242-130281243	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs532565285	chr4:130281243-130281244	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs148500125	chr4:130281283-130281284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs28612520	chr4:130281352-130281353	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs530344410	chr4:130281449-130281450	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs548537236	chr4:130281504-130281505	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs566877433	chr4:130281514-130281515	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs72688760	chr4:130281557-130281558	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs551915909	chr4:130281559-130281560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs377261713	chr4:130281570-130281571	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs552692744	chr4:130281580-130281581	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs184631334	chr4:130281611-130281612	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs28580176	chr4:130281632-130281633	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs538021490	chr4:130281726-130281727	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
Colorectal cancer	20459617	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Colorectal cancer	16272173	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Neuroblastoma	21899760	CNVD
Renal cell carcinoma	18194544	CNVD
Olfactory neuroblastoma	18408657	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	16864856	CNVD
Hodgkin''s lymphoma	18641027	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Gastric cancer	16891809	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Lung squamous cell carcinoma	22363434	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:36 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:130277200-130284000	Weak transcription	Colon Smooth Muscle	Colon
2	chr4:130277600-130284200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr4:130279000-130281600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr4:130279200-130281600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr4:130279400-130280400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr4:130279600-130280200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
7	chr4:130279600-130280400	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr4:130279600-130280400	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr4:130279600-130280400	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr4:130279600-130280400	Enhancers	HUVEC	blood vessel
11	chr4:130279600-130280400	Enhancers	NH-A	brain
12	chr4:130279800-130280200	Enhancers	HSMMtube	muscle
13	chr4:130279800-130280400	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr4:130279800-130280400	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr4:130279800-130280400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr4:130279800-130280400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
17	chr4:130279800-130281200	Enhancers	Fetal Lung	lung
18	chr4:130280000-130280200	Enhancers	Osteobl	bone
19	chr4:130280000-130280400	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr4:130280000-130280400	Enhancers	Breast Myoepithelial Primary Cells	Breast
21	chr4:130280000-130280400	Bivalent Enhancer	HMEC	breast
22	chr4:130280400-130283600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
23	chr4:130280400-130283600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
24	chr4:130280400-130283800	Weak transcription	HUES48 Cell Line	embryonic stem cell
25	chr4:130280400-130283800	Weak transcription	HUES6 Cell Line	embryonic stem cell
26	chr4:130280400-130283800	Weak transcription	HUES64 Cell Line	embryonic stem cell
27	chr4:130280400-130283800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
28	chr4:130280400-130283800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
29	chr4:130280400-130283800	Weak transcription	HUVEC	blood vessel
30	chr4:130280400-130284000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
31	chr4:130280400-130284400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr4:130280400-130284600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
33	chr4:130280400-130284600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr4:130281600-130284400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr4:130283600-130284600	Enhancers	ES-I3 Cell Line	embryonic stem cell
36	chr4:130283600-130284800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links